|
|
|
Insider
Information: |
Eshelman Fredric N |
Relationship: |
10% Owner |
City: |
Wilmington |
State: |
NC |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
8,151,654 |
|
Indirect Shares
|
3,933,809 |
|
|
Direct
Value |
$97,306,212 |
|
|
Indirect Value
|
$13,896,898 |
|
|
Total
Shares |
12,085,463 |
|
|
Total
Value |
$111,203,111 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
7
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
7
|
3
|
|
|
|
Gain/Loss Ratio : |
-7.0
|
-3.0
|
Percentage
Gain/Loss : |
-45.7%
|
-43.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pharmaceutical Product Developme... |
PPDI |
Executive Chairman, Di... |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
Furiex Pharmaceuticals, Inc. |
FURX |
Director, 10% Owner |
2014-07-02 |
0 |
2014-07-02 |
0 |
Premium* |
|
Bausch Health Companies Inc |
BHC |
Director |
2017-05-05 |
38,298 |
2016-03-11 |
0 |
Premium* |
|
G1 Therapeutics Inc |
GTHX |
Director, 10% Owner |
2017-11-13 |
250,000 |
2017-11-13 |
3,439,151 |
Premium* |
|
Eyenovia Inc |
EYEN |
Director |
2020-09-11 |
1,292,787 |
2020-09-11 |
319,085 |
Premium* |
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2020-11-25 |
6,570,569 |
2020-11-25 |
175,573 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PPDI |
Pharmaceutical Product De... |
officerTitle |
|
2005-12-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
47,000 |
4,915,263 |
|
- |
|
PPDI |
Pharmaceutical Product De... |
officerTitle |
|
2007-03-01 |
4 |
S |
$31.06 |
$1,633,876 |
D/D |
(52,133) |
9,131,827 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
officerTitle |
|
2007-03-01 |
4 |
S |
$31.42 |
$981,403 |
D/D |
(31,200) |
9,100,627 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2009-06-18 |
4 |
A |
$0.00 |
$0 |
I/I |
11,258 |
11,258 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2009-06-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,258) |
7,744,368 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2009-08-28 |
4 |
D |
$0.00 |
$0 |
D/D |
(500,000) |
7,244,368 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2009-08-28 |
4 |
A |
$0.00 |
$0 |
I/I |
500,000 |
500,000 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2010-04-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
7,144,368 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2010-04-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
7,134,368 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2010-05-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
36,497 |
7,097,871 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2010-09-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
75,000 |
7,022,871 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2010-09-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
62,500 |
6,960,371 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2010-09-29 |
4 |
D |
$0.00 |
$0 |
I/I |
(37,500) |
462,500 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2010-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
6,997,871 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2010-10-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(38,000) |
424,500 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2010-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
38,000 |
7,035,871 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2011-01-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(15,000) |
409,500 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2011-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
7,050,871 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2011-04-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
83,000 |
6,969,741 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2011-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
6,984,741 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2011-04-14 |
4 |
D |
$0.00 |
$0 |
I/I |
(15,000) |
394,500 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2011-12-05 |
4 |
D |
$33.25 |
$232,242,638 |
D/D |
(6,984,741) |
0 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Executive Chairman |
|
2011-12-05 |
4 |
D |
$33.25 |
$13,547,480 |
I/I |
(407,443) |
0 |
0 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-05-18 |
4 |
B |
$14.52 |
$182,937 |
D/D |
12,599 |
604,088 |
2.39 |
- |
|
FURX |
Furiex Pharmaceuticals, I... |
Director |
|
2011-05-19 |
4 |
B |
$14.12 |
$177,898 |
D/D |
12,599 |
616,687 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|